LEADER 00778nam0-22002891i-450- 001 990006588320403321 005 20001010 035 $a000658832 035 $aFED01000658832 035 $a(Aleph)000658832FED01 035 $a000658832 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $a<>House of Lords. Oxford$ePhilip Allan$fDonald Shell 210 $aTotowa [N.J.]$cBarnes & Noble Books$d1988 215 $aVIII, 231 p., 23 cm 676 $a328.41 700 1$aShell,$bDonald$0246838 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006588320403321 952 $aI C 114$b6828$fFSPBC 959 $aFSPBC 996 $aHouse of Lords. Oxford$9623099 997 $aUNINA DB $aGEN01 LEADER 01746nam 2200397Ka 450 001 9910695524703321 005 20070222165322.0 035 $a(CKB)5470000002371526 035 $a(OCoLC)84854074 035 $a(EXLCZ)995470000002371526 100 $a20070222d2006 ua 0 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aReview and analysis of cost-effectiveness analyses for two Medicare-covered services$b[electronic resource] $ea study /$fconducted by staff from the Institute for Clinical Research and Health Policy Studies at the New England Medical Center for the Medicare Payment Advisory Commission 210 1$aWashington, DC :$cMedPAC,$d[2006] 215 $a30 pages $cdigital, PDF file 225 1 $a[MedPAC contract research series] ;$vno. 06-2 300 $aTitle from title screen (viewed on Feb. 22, 2007). 300 $a"June 2006." 517 $aReview and analysis of cost-effectiveness analyses for two Medicare-covered services 606 $aColon (Anatomy)$xCancer$xDiagnosis$zUnited States$xCost effectiveness 606 $aImplantable cardioverter-defibrillators$zUnited States$xCost effectiveness 615 0$aColon (Anatomy)$xCancer$xDiagnosis$xCost effectiveness. 615 0$aImplantable cardioverter-defibrillators$xCost effectiveness. 700 $aAlhun$b Ezgi$01396209 701 $aCohen$b Joshua$01396210 701 $aNeumann$b Peter$0499149 712 02$aMedicare Payment Advisory Commission (U.S.) 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910695524703321 996 $aReview and analysis of cost-effectiveness analyses for two Medicare-covered services$93455917 997 $aUNINA